Dr. Jeffrey Mccrary, M.D.
Gastroenterology (Gastroenterology Physician)
- Medicare participating
At a glance
- Medical school
- University of Mississippi School of Medicine (2007)
- Years since graduation
- 19
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 505
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Medical school: University of Mississippi School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
MS license 20652
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- St Dominic-Jackson Memorial Hospital Jackson, MS
- Merit Health River Oaks Flowood, MS
- Baptist Medical Center-Yazoo Yazoo City, MS
Medical groups
- St. Dominic Medical Associates LLC (132 clinicians)
- Gastrointestinal Associates PA (46 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 505
- Services billed
- 14,661
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Injection, vedolizumab, 1 mg | 9,000 | 19 |
| Injection, infliximab, excludes biosimilar, 10 mg | 1,477 | 16 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 451 | 49 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 254 | 49 |
| Biopsy of large bowel using a flexible endoscope | 141 | 141 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 122 | 119 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 113 | 112 |
| Established patient office or other outpatient visit, 30-39 minutes | 109 | 90 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 67 | 54 |
| New patient office or other outpatient visit, 45-59 minutes | 53 | 53 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Omeprazole Other prescribers in Flowood, MS | 266 |
| Gavilyte-C (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Flowood, MS | 92 |
| Peg 3350-Electrolyte (sodium chloride/nahco3/kcl/peg) | 73 |
| Pantoprazole Sodium Other prescribers in Flowood, MS | 68 |
| Colesevelam Hcl Other prescribers in Flowood, MS | 63 |
| Peg-3350 And Electrolytes (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Flowood, MS | 55 |
| Dicyclomine Hcl Other prescribers in Flowood, MS | 52 |
| Clenpiq (sod picosulf/mag ox/citric ac) | 50 |
| Linzess (linaclotide) Other prescribers in Flowood, MS | 46 |
| Gavilyte-G (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Flowood, MS | 46 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 12 payments worth $284 in total to this clinician.
| AbbVie Inc. | $73.38 |
|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $60.47 |
| Phathom Pharmaceuticals, Inc. | $49.24 |
| Intercept Pharmaceuticals, Inc. | $35.24 |
| Janssen Biotech, Inc. | $24.69 |
| Genzyme Corporation | $24.31 |
| Ipsen Biopharmaceuticals, Inc | $16.21 |
| Food and Beverage | $284 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.